BLTE

Belite Bio, Inc - American Depositary Shares (BLTE)

About Belite Bio, Inc - American Depositary Shares (BLTE)

Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.

Details

Daily high

$58.01

Daily low

$55.51

Price at open

$56.76

52 Week High

$86.53

52 Week Low

$32.50

Market cap

1.8B

Dividend yield

0.00%

Volume

20,440

Avg. volume

37,699

P/E ratio

-47.71

Belite Bio, Inc - American Depositary Shares News